These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30853393)

  • 41. The Optimal Killer Cell Immunoglobulin-Like Receptor Donor-We Can Recognize, but Can We Search?
    Mehta RS; Oran B
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):e3-e4. PubMed ID: 30472435
    [No Abstract]   [Full Text] [Related]  

  • 42. Successful Transfer of Umbilical Cord Blood CD34
    Dolstra H; Roeven MWH; Spanholtz J; Hangalapura BN; Tordoir M; Maas F; Leenders M; Bohme F; Kok N; Trilsbeek C; Paardekooper J; van der Waart AB; Westerweel PE; Snijders TJF; Cornelissen J; Bos G; Pruijt HFM; de Graaf AO; van der Reijden BA; Jansen JH; van der Meer A; Huls G; Cany J; Preijers F; Blijlevens NMA; Schaap NM
    Clin Cancer Res; 2017 Aug; 23(15):4107-4118. PubMed ID: 28280089
    [No Abstract]   [Full Text] [Related]  

  • 43. Development of a new anti-CD123 monoclonal antibody to target the human CD123 antigen as an acute myeloid leukemia cancer stem cell biomarker.
    Abdollahpour-Alitappeh M; Razavi-Vakhshourpour S; Abolhassani M
    Biotechnol Appl Biochem; 2018 Nov; 65(6):841-847. PubMed ID: 29972607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical studies of ABMT in acute myeloid leukaemia.
    Linch DC; Burnett AK
    Clin Haematol; 1986 Feb; 15(1):167-86. PubMed ID: 3516488
    [No Abstract]   [Full Text] [Related]  

  • 45. Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance.
    Hoang VT; Zepeda-Moreno A; Ho AD
    Biotechnol J; 2012 Jun; 7(6):779-88. PubMed ID: 22588704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tracing the origins of relapse in acute myeloid leukaemia to stem cells.
    Shlush LI; Mitchell A; Heisler L; Abelson S; Ng SWK; Trotman-Grant A; Medeiros JJF; Rao-Bhatia A; Jaciw-Zurakowsky I; Marke R; McLeod JL; Doedens M; Bader G; Voisin V; Xu C; McPherson JD; Hudson TJ; Wang JCY; Minden MD; Dick JE
    Nature; 2017 Jul; 547(7661):104-108. PubMed ID: 28658204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia.
    Lewis NR; Pallis M; Russell NH
    Exp Hematol; 2000 May; 28(5):535-42. PubMed ID: 10812243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial.
    Quarello P; Fagioli F; Basso G; Putti MC; Berger M; Luciani M; Rizzari C; Menna G; Masetti R; Locatelli F
    Br J Haematol; 2015 Nov; 171(4):566-73. PubMed ID: 26223157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maturation hierarchy of leukemic stem cells.
    Löwenberg B; Terpstra W
    Stem Cells; 1998; 16 Suppl 1():85-8; discussion 89. PubMed ID: 11012150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High frequency of cross-lineage antigenic expression in acute myeloid leukaemia cells of elderly patients.
    Marotta G; Sorio R; Gattei V; Bullian PL; De Rosa L; Mancardi S; Attadia V; Carbone A; Monfardini S; Zagonel V
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():20. PubMed ID: 2627601
    [No Abstract]   [Full Text] [Related]  

  • 51. Harnessing the immune system in acute myeloid leukaemia.
    Austin R; Smyth MJ; Lane SW
    Crit Rev Oncol Hematol; 2016 Jul; 103():62-77. PubMed ID: 27247119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-dose melphalan-based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemia.
    Steckel NK; Groth C; Mikesch JH; Trenschel R; Ottinger H; Kordelas L; Mueller-Tidow C; Schliemann C; Reicherts C; Albring JC; Silling G; Schmidt E; Berdel WE; Lenz G; Ditschkowski M; Beelen DW; Stelljes M
    Br J Haematol; 2018 Mar; 180(6):840-853. PubMed ID: 29468631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allogeneic haematopoietic cell transplantation for adult acute myeloid leukaemia in second remission: a retrospective study of the Adult Acute Myeloid Leukaemia Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT).
    Konuma T; Yanada M; Yamasaki S; Kuwatsuka Y; Fukuda T; Kobayashi T; Ozawa Y; Uchida N; Ota S; Hoshino T; Takahashi S; Kanda Y; Ueda Y; Takanashi M; Kanda J; Ichinohe T; Atsuta Y; Yano S
    Br J Haematol; 2018 Jul; 182(2):245-250. PubMed ID: 29808919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.
    Wong TN; Ramsingh G; Young AL; Miller CA; Touma W; Welch JS; Lamprecht TL; Shen D; Hundal J; Fulton RS; Heath S; Baty JD; Klco JM; Ding L; Mardis ER; Westervelt P; DiPersio JF; Walter MJ; Graubert TA; Ley TJ; Druley T; Link DC; Wilson RK
    Nature; 2015 Feb; 518(7540):552-555. PubMed ID: 25487151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced intensity conditioning (RIC) haematopoietic cell transplants in elderly patients with AML.
    Niederwieser D; Lange T; Cross M; Basara N; Al-Ali H
    Best Pract Res Clin Haematol; 2006; 19(4):825-38. PubMed ID: 16997186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A critical review of which children with acute myeloid leukaemia need stem cell procedures.
    Hasle H
    Br J Haematol; 2014 Jul; 166(1):23-33. PubMed ID: 24749666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biology and Clinical Relevance of Acute Myeloid Leukemia Stem Cells.
    Reinisch A; Chan SM; Thomas D; Majeti R
    Semin Hematol; 2015 Jul; 52(3):150-64. PubMed ID: 26111462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel strategies to prevent relapse after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes.
    Kekre N; Koreth J
    Curr Opin Hematol; 2015 Mar; 22(2):116-22. PubMed ID: 25575033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aldehyde dehydrogenases in acute myeloid leukemia.
    Smith C; Gasparetto M; Humphries K; Pollyea DA; Vasiliou V; Jordan CT
    Ann N Y Acad Sci; 2014 Mar; 1310():58-68. PubMed ID: 24641679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. (Lymph)angiogenic influences on hematopoietic cells in acute myeloid leukemia.
    Lee JY; Kim HJ
    Exp Mol Med; 2014 Nov; 46(11):e122. PubMed ID: 25412683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.